Table 1.
Relationship between AURKAPS1 expression and the clinicopathologic features of liver cancer patients.
| Clinicopathologic features | No | Foldchange (Mean ± SD) |
P value |
|---|---|---|---|
| Sex | |||
| male | 93 | 2.99 ± 3.18 | 0.626 |
| female | 31 | 3.33 ± 3.54 | |
| Age | |||
| ≥50 years old | 81 | 2.66 ± 2.92 | 0.052 |
| <50 years old | 43 | 3.86 ± 3.75 | |
| History of hepatitis | |||
| no | 64 | 3.52 ± 3.45 | 0.120 |
| yes | 60 | 2.61 ± 3.01 | |
| Tumour size | |||
| <5 cm | 59 | 2.47 ± 2.85 | 0.006* |
| ≥5 cm | 65 | 3.63 ± 3.53 | |
| Lymph node metastasis | |||
| no | 99 | 2.90 ± 3.15 | 0.240 |
| yes | 25 | 3.76 ± 3.67 | |
| TNM stage | |||
| I, II | 49 | 2.35 ± 3.50 | 0.046* |
| III, IV | 75 | 3.55 ± 3.03 | |
*P < 0.05 compared with the control group. The means ± SD are shown. Statistical analysis was conducted using one-way analysis of variance (ANOVA).*P < 0.05 compared with the control group. The means ± SD are shown. Statistical analysis was conducted using one-way analysis of variance (ANOVA).